Ionis Pharmaceuticals Inc (FRA:ISI)
€ 33.48 -0.13 (-0.39%) Market Cap: 5.40 Bil Enterprise Value: 4.42 Bil PE Ratio: 0 PB Ratio: 8.55 GF Score: 60/100

Ionis Pharmaceuticals Inc at Citi BioPharma Conference Transcript

Sep 07, 2023 / 05:50PM GMT
Release Date Price: €36.97 (+1.01%)
David Neil Lebowitz
Citigroup Inc., Research Division - Research Analyst

David Lebowitz. I am one of the biotech analysts here at Citi. And thank you for attending the Citi 18th Annual Biopharma Conference. Happy to have on stage with me from Ionis from warm San Diego. Oh, it's pretty warm here today as well, actually. I guess if you could start by introducing yourselves and then maybe walk through the top-level mission of Ionis and the technology behind that mission.

Elizabeth L. Hougen
Ionis Pharmaceuticals, Inc. - Executive VP of Finance & CFO

Sure. Happy to. Thank you for having us, David. I'm Beth Hougen, Ionis' Chief Financial Officer, and I've been with the company now for over 23 years. So I'm looking forward to talking a bit more about Ionis today because we really are in the midst of an important transformation for the company.

D. Wade Walke
Ionis Pharmaceuticals, Inc. - SVP of IR

And I'm Wade Walke, I'm the Head of Investor Relations.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot